StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
633
This month
12
This week
2
This year
61
Today
1
Yesterday
1
Publishing Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
5
2023 - 04 - 12
3
2023 - 03 - 28
4
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 11
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 29
3
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
3
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 10 - 27
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Sector
Communications
6
Consumer durables
1
Consumer non-durables
13
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
633
Manufacturing
65
Mining, quarrying, and oil and gas extraction
1
N/a
123
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Active
10
Agreement
8
Ajovy
8
Alzheimer's
9
America
38
Application
11
Approval
13
Asia
13
Austedo
9
Avt02
11
Avt04
11
Biosimilar
42
Business
12
Cancer
21
Children
18
Clinical-trials-phase-iii
8
Collaboration
9
Conference
20
Dermatitis
8
Disease
36
Drug
44
Dupixent
34
Earnings
14
Europe
15
Events
10
Expected
12
Fda
22
Financial
21
Global
111
Growing
17
Growth
133
Health
11
Libtayo
8
License
11
Liver
8
Market
314
Migraine
9
N/a
516
Pharm-country
18
Pharma
12
Pharmaceuticals
9
Phase 3
15
Positive
14
Reach
16
Report
95
Research
59
Respiratory
10
Results
48
Review
8
Set
13
Stelara
12
Study
21
System
11
Teva
53
Therapeutics
64
Therapy
14
Treatment
76
Trial
12
Update
20
Year
8
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1796
Abbvie inc.
1029
Accenture plc
602
Alphabet inc.
1304
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4312
Astrazeneca plc
668
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1768
Boston scientific corporation
577
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1711
Ericsson
1614
Extreme networks, inc.
581
First bank
600
Ford motor company
643
Gartner, inc.
595
General electric company
918
Glaxosmithkline plc
888
Honeywell international inc.
1791
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
655
Johnson & johnson
4600
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
973
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1204
Morgan stanley
4291
Nokia corp
982
Nokia corporation
906
Northrop grumman corporation
589
Novartis ag
1245
Novo nordisk a/s
634
Oracle corporation
1161
Orange
7221
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4553
Sap se
1480
Snowflake inc.
796
Stellantis n.v
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1630
Verizon communications inc.
1221
X financial
678
Symbols
ABBV
130
ABT
43
ALB
8
ALC
4
ALKS
5
ALNY
4
ALPMF
27
ALPMY
27
ALVO
84
AMGN
83
ATR
5
ATRS
4
AVDL
4
AZN
85
AZNCF
85
BAX
25
BDX
4
BHC
33
BIIB
28
BMY
37
CMPI
4
CMXHF
6
CSLLY
6
DNLI
5
ENDP
28
ENDPQ
19
FNCTF
6
GILD
10
GLAXF
148
GSK
148
JAZZ
8
JNJ
81
KMDA
86
LLY
61
MDT
9
MMM
9
MNK
15
MNKKQ
13
MNKPF
10
MS
5
NTLA
6
NVO
15
NVS
206
NVSEF
206
PFE
29
PHG
12
PRGO
6
RBGLY
11
RBGPF
11
REGN
72
SNY
224
SNYNF
224
TAK
20
TARO
5
TEVA
64
TEVJF
633
TMO
8
UCBJF
7
UCBJY
7
VTRS
103
Exchanges
Nasdaq
633
Nyse
436
Crawled Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2024 - 01 - 19
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
6
2023 - 03 - 28
4
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
4
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Crawled Time
00:00
32
00:20
6
01:00
17
02:00
12
03:00
14
04:00
9
04:20
5
05:00
10
06:00
16
07:00
16
08:00
26
08:20
1
09:00
43
10:00
24
11:00
23
12:00
44
12:15
1
12:20
9
12:30
3
13:00
36
13:20
8
13:30
7
14:00
19
14:20
2
14:30
5
15:00
21
15:20
1
15:30
9
16:00
26
16:20
4
17:00
23
18:00
24
19:00
23
20:00
21
20:20
4
21:00
24
22:00
30
23:00
35
Source
ir.biolinerx.com
1
ir.vtvtherapeutics.com
1
www.biospace.com
117
www.globenewswire.com
96
www.prnewswire.com
418
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Teva pharmaceutical industries ltd
save search
Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published:
2024-02-26
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.63%
|
O:
3.06%
H:
0.0%
C:
-2.34%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-3.96%
|
O:
0.23%
H:
1.16%
C:
0.08%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-5.17%
|
O:
-0.19%
H:
0.23%
C:
-2.02%
UTHR
|
$234.47
0.18%
0.16%
520K
|
Health Technology
|
3.28%
|
O:
-0.48%
H:
1.17%
C:
-1.04%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
7.63%
|
O:
0.38%
H:
0.44%
C:
-0.23%
reach
research
market
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per Share
Published:
2024-02-26
(Crawled : 10:00)
- globenewswire.com
ALVO
|
$13.4
0.53%
0.45%
26
|
n/a
|
-16.41%
|
O:
11.35%
H:
0.84%
C:
-3.25%
KMDA
|
$5.1
0.99%
-0.99%
5.3K
|
Health Technology
|
-15.61%
|
O:
0.0%
H:
1.6%
C:
-0.49%
million
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
Published:
2024-02-24
(Crawled : 04:20)
- globenewswire.com
KMDA
|
$5.1
0.99%
-0.99%
5.3K
|
Health Technology
|
Email alert
Add to watchlist
ALVO
|
$13.4
0.53%
0.45%
26
|
n/a
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
simlandi
first
biosimilar
approval
teva
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-6.68%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-3.83%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-3.97%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-4.56%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-4.08%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
-1.78%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
15K
|
Health Technology
|
-7.9%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-4.08%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-8.95%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
-1.52%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
10.47%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-5.82%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$65.26
0.51%
-4.38%
5.9K
|
Manufacturing
|
28.21%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.49
-0.42%
-1.11%
55K
|
Manufacturing
|
-14.66%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-9.46%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-3.61%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-1.67%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-0.92%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-3.77%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-3.85%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
-0.15%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
8.85%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-3.5%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published:
2024-02-21
(Crawled : 09:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
9.18%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-4.55%
|
O:
0.8%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-4.09%
|
O:
-0.25%
H:
0.0%
C:
0.0%
KPTI
|
$1.09
-3.54%
-4.15%
1.6M
|
Health Technology
|
-9.92%
|
O:
-1.65%
H:
3.36%
C:
1.68%
CKPT
|
$1.435
-1.03%
-1.4%
0
|
Health Technology
|
-27.27%
|
O:
0.0%
H:
1.26%
C:
-3.03%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
8.93%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
year
reach
market
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published:
2024-02-20
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
2.06%
|
O:
2.72%
H:
0.0%
C:
-0.8%
TEVA
|
$13.01
1.01%
-0.62%
8.1M
|
Health Technology
|
-0.08%
|
O:
1.31%
H:
0.67%
C:
-0.91%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.8%
|
O:
2.53%
H:
0.0%
C:
0.0%
antibody
meeting
teva
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.608
0.73%
-17.59%
5.6K
|
Health Technology
|
-54.93%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
2.1%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-3.52%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$17.05
0.65%
0.79%
46K
|
Manufacturing
|
-54.17%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-0.77%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-5.23%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-3.99%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.18%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
Published:
2024-02-15
(Crawled : 12:00)
- globenewswire.com
ALVO
|
$13.4
0.53%
0.45%
26
|
n/a
|
-14.65%
|
O:
0.32%
H:
2.98%
C:
0.32%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-4.23%
|
O:
-0.19%
H:
1.6%
C:
1.24%
KMDA
|
$5.1
0.99%
-0.99%
5.3K
|
Health Technology
|
-13.64%
|
O:
1.66%
H:
1.96%
C:
0.49%
avt04
stelara
biosimilar
expected
global
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-1.64%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-0.19%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-2.11%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-5.7%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
1.37%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-0.53%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.93%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
5.8%
1.2M
|
Health Technology
|
-14.77%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-5.83%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$558.779
3.26%
-19.1%
23
|
Health Technology
|
11.76%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-6.95%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
1.37%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
13.6%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$57.57
3.38%
0.02%
93K
|
Professional, Scientific, and T...
|
15.95%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$574.59
4.78%
3.34%
2.2M
|
Health Technology
|
4.98%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-6.94%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-5.1%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-0.36%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-0.53%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$41.02
1.54%
0.19%
2.2M
|
Health Technology
|
3.53%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-2.82%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
-4.43%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.93%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.45
1.31%
1.36%
16K
|
Health Technology
|
-25.29%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$193.18
-0.48%
5.8%
1.2M
|
Health Technology
|
-14.77%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
16.09%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-5.83%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-6.95%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
1.37%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
13.6%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-0.36%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-0.53%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$404.91
1.25%
1.43%
730K
|
Health Technology
|
-2.68%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.93%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
5.8%
1.2M
|
Health Technology
|
-14.77%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
16.09%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-5.83%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-4.81%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
16.27%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.49
-0.42%
-1.11%
55K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-6.74%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-1.66%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-4.43%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
0.41%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
0.24%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.12
0.87%
0.93%
430K
|
Health Technology
|
-16.97%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$404.91
1.25%
1.43%
730K
|
Health Technology
|
-3.25%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.37
-2.27%
-7.02%
2
|
Health Technology
|
-8.14%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.65
-0.52%
-0.58%
11
|
Health Technology
|
-10.7%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$193.18
-0.48%
5.8%
1.2M
|
Health Technology
|
-21.07%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
15.37%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.08
1.72%
1.7%
1.3K
|
Health Technology
|
-4.49%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-7.1%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
13.6%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-2.15%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
-0.15%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-1.65%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-3.12%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
-4.15%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
0.99%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
13.8%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-6.04%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Acrivon Therapeutics Appoints Seasoned Industry Executive Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
Published:
2024-02-08
(Crawled : 13:00)
- globenewswire.com
ACRV
|
$9.82
3.26%
3.16%
320K
|
|
169.04%
|
O:
5.75%
H:
0.0%
C:
-8.29%
VIGL
|
$2.65
-6.69%
-7.17%
61K
|
|
-7.02%
|
O:
1.05%
H:
1.52%
C:
-1.39%
therapeutics
Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published:
2024-02-08
(Crawled : 05:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
471.43%
|
O:
-14.29%
H:
16.67%
C:
0.0%
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-6.19%
|
O:
0.82%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
|
0.61%
|
O:
-1.64%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
3.9M
|
Health Technology
|
-3.24%
|
O:
-0.34%
H:
0.0%
C:
-1.2%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-4.45%
|
O:
-1.57%
H:
0.26%
C:
-0.47%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-1.86%
|
O:
-0.48%
H:
0.16%
C:
0.0%
BAX
|
$41.02
1.54%
0.19%
2.2M
|
Health Technology
|
4.16%
|
O:
-0.96%
H:
5.91%
C:
3.74%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
-6.02%
|
O:
-1.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
-0.19%
|
O:
-2.25%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-7.55%
|
O:
0.38%
H:
0.34%
C:
-0.72%
america
growth
market
Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry
Published:
2024-02-07
(Crawled : 13:30)
- biospace.com/
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
canada
teva
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
-2.56%
43.47%
21K
|
Health Technology
|
-14.57%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
4.83%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-6.68%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$65.26
0.51%
-4.38%
5.9K
|
Manufacturing
|
39.56%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
News
|
$9.49
-0.42%
-1.11%
55K
|
Manufacturing
|
-12.86%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
1.94%
1.7M
|
Health Technology
|
-5.76%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-4.7%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-3.9%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
0.04%
1.4M
|
Health Technology
|
4.83%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-0.55%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
-0.87%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$404.91
1.25%
1.43%
730K
|
Health Technology
|
-2.7%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
|
1.14%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.67
0.77%
0.78%
380K
|
Health Technology
|
-12.06%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
5.68%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
-13.46%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Global Respiratory Drug Delivery Market Report 2024 - A US$67 Billion Market - Trends in Metered Dose Inhaler (MDI) Technology to Propel the Market
Published:
2024-01-31
(Crawled : 17:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
1.21%
3.5M
|
Health Technology
|
-8.25%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
PHG
|
News
|
$21.01
1.94%
0.0%
2M
|
Health Technology
|
-1.96%
|
O:
-0.09%
H:
0.93%
C:
-1.31%
drug
propel
report
respiratory
global
trends
technology
market
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
AGBA
|
$2.97
137.6%
54.87%
66M
|
Finance
HKIT
|
$1.33
30.39%
27.14%
39K
|
Technology Services
VRT
4
|
$79.17
4.08%
19.36%
6.6M
|
Electronic Technology
FOA
4
|
$0.5144
-8.16%
15.43%
20
|
Finance and Insurance
EAST
|
$1.0835
16.17%
15.21%
100
|
Commercial Services
BOF
|
$1.17
6.36%
14.73%
15K
|
TSLA
|
News
|
$144.68
1.85%
9.01%
93M
|
Consumer Durables
BNED
|
$0.2064
2.64%
8.96%
1.4M
|
Retail Trade
HLTH
|
$0.15
6.38%
7.84%
21K
|
LRN
4
|
$58.2
0.17%
7.56%
950K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.